Form 4: Elanco Director Kapila K. Anand Reports Acquisition of Deferred Stock Units

Director Kapila K. Anand reports acquisition of deferred stock units in Elanco Animal Health Inc. through a director deferral plan.

Summary

• Kapila K. Anand, a director of Elanco Animal Health Inc., filed a Form 4 on April 02, 2025, reporting a transaction that occurred on March 31, 2025.
• The transaction involved the acquisition of 821.4286 deferred stock units (DSUs) under the company's Directors' Deferral Plan.
• These DSUs are the economic equivalent of Elanco common stock and were acquired as a result of deferred director cash retainer fees.
• The price per share used to calculate the number of DSUs was $10.50, which was the closing price of Elanco common stock on March 31, 2025.
• Following the reported transaction, Ms. Anand beneficially owns 7,481.3664 deferred stock units.
• The DSUs will be settled in stock upon Ms. Anand's separation of service from the Company's Board of Directors.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The director is increasing their stake in the company, which is generally a good sign. The transaction is part of a standard compensation plan.

Positives

• The acquisition of deferred stock units by a director demonstrates alignment with the company's long-term performance.
• The Directors' Deferral Plan allows directors to invest in the company's future growth.

Future Outlook

The deferred stock units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

Industry Context

Directors receiving stock-based compensation is a common practice in publicly traded companies to align their interests with those of shareholders. Deferred stock unit plans are a variation of this, allowing directors to defer cash compensation into stock.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• Companies like Zoetis and Merck Animal Health also utilize equity-based compensation for their directors.
• The specific structure and terms of these plans can vary, but the underlying goal is to incentivize directors to focus on long-term value creation.

Related Party Transactions

• The acquisition of deferred stock units under the Directors' Deferral Plan is a related party transaction.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with company performance.

Key Dates

Keywords

Form 4, Elanco Animal Health Inc, Kapila K. Anand, Deferred Stock Units, Director Deferral Plan, Beneficial Ownership, ELAN